ANGIOLINE took part in the Moscow Congress of Cardiologists
Angioline presented its stand at the Second Moscow Congress of Cardiologists, which was held in Moscow on October 8th and 9th. As part of the event, which again brought together at one site leading world experts in the field of modern clinical and experimental cardiology, new achievements in the diagnosis and treatment of heart rhythm disturbances, heart failure, acute coronary syndrome, valvular heart disease and other relevant topics were discussed. The Congress was held with the participation of Moscow Department of Health, Research Institute of Healthcare and Medical Management, Russian Cardiology Society and other well-known institutions and associations. Congress participants were able to communicate with Angioline specialists and get acquainted with samples of catheters and stents included in the company's production line, including the flagship product (Calipso coronary stent) and other modern developments. For Angioline, participation in such prestigious events is one more confirmation of the status of the company as a leading Russian manufacturer of medical devices for interventional cardiology and another opportunity for professional dialogue with key foreign and domestic specialists. The Moscow Congress of Cardiologists was first held in 2017, it was attended by more than 3,000 people from 86 cities of Russia, Europe, Israel and the United States. This year the list of participants and speakers has expanded even more: in particular, such well-known experts as Peter Vidimsky, Joseph Alpert and Lina Badimon, as well as other authoritative experts, addressed the guests. Angioline company thanks the organizers for holding the congress and invitation to participate in this important event for the industry.